Fischer et al identified that miR-17,miR-18a, miR-20a and miR-93 all function as the CBF-AML fusion proteins in negative regulating their target RUNX1 and the RUNX1-miR-221-KIT axis [74]. The gene discussed is KIT; the disease is acute myeloid leukemia.